Description
Opana (Oxymorphone) ER 40mg Tablets Online
Opana is a powerful semi-synthetic opioid analgesic (painkiller). It has a selective affinity for the mu-opioid receptor, whereas oxycodone has a weaker mu-receptor affinity and greater kappa-receptor affinity. Oxymorphone has lower protein binding (10% to 12%) compared with morphine (30% to 35%) or oxycodone (45%). Its highly lipophilic properties facilitate its transit across the blood-brain barrier.
Whether in a dedicated pain-management clinic or in a community pharmacy, pharmacists can provide valuable education and treatment recommendations to patients and clinicians. Pain programs, jointly managed by pharmacists, nurse practitioners, specialists in behavioral medicine and functional restoration, and specialty pain physicians, can enhance the satisfaction of patients and health care professionals, improve clinical outcomes, and minimize the need for secondary pain referrals.
Order Opana (Oxymorphone) Tablet right now through our site dozeoutlet.com for hassle-free deliveries worldwide.
Differences among opioids influence individual patient response and tolerability, risks and benefits in specific disease states, the likelihood of drug interactions, and ease of monitoring. Differences among patients with respect to genetic factors, age, sex, and the prior use of opioids also contribute to the variability of response to individual opioids Consequently, when selecting the LA opioid, clinicians cannot reliably predict how a given patient will respond. Patients with chronic pain usually require consecutive trials of several LA opioids before they find one that provides adequate analgesia with acceptable tolerability.7–9 For this reason, it is essential to have multiple LA opioids from which to choose.
Oxymorphone ER has minimal potential for pharmacokinetic interactions, its use with sedatives, tranquilizers, hypnotics, phenothiazines, and other central nervous systems (CNS) depressants can produce additive effects. Hence, as with other opioids, vigilance is required in preventing pharmacodynamic interactions during therapy with oxymorphone ER.
